Skip to main content

Animations

MJFF Publications

5211 - 5220 of 9038 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2018
  • 2022
  • 2023
  • 2023
  • 2023
  • 2019
  • 2019
  • 2023
  • An Overview of the Active Clinical Trials for Parkinson’s Disease Psychosis
    2022
    Summary Details
    RESTRICTED
    Title: An Overview of the Active Clinical Trials for Parkinson’s Disease Psychosis
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/nmt-2022-0020
    Citation Count: 0
  • Summary Details
    OPEN
    Title: In Silico Studies Comparing the Adjuvant Therapies Approved for Parkinson’s disease
    Journal Name: Journal of Drug Delivery and Therapeutics
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.22270/jddt.v11i3-s.4813
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Леводопа/карбідопа пролонгованого вивільнення в лікуванні хвороби Паркінсона
    Journal Name: INTERNATIONAL NEUROLOGICAL JOURNAL
    Publisher: Publishing House Zaslavsky
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.22141/2224-0713.3.97.2018.133682
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study
    Journal Name: Diabetes Care
    Publisher: American Diabetes Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2337/dc22-1705
    Citation Count: 134
  • Summary Details
    OPEN
    Title: Unconventional initiation of PINK1/Parkin mitophagy by Optineurin
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2023.04.021
    Citation Count: 113
  • Summary Details
    OPEN
    Title: Long-term exposure to low-level particulate air pollution and Parkinson's disease diagnosis - A Finnish register-based study
    Journal Name: Environmental Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.envres.2023.115944
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Genetic Testing in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29500
    Citation Count: 30
  • Summary Details
    OPEN
    Title: The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population‐Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27864
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease
    Journal Name: Journal of Medical Genetics
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1136/jmedgenet-2019-106283
    Citation Count: 71
  • Summary Details
    OPEN
    Title: FBXL4 suppresses mitophagy by restricting the accumulation of NIX and BNIP3 mitophagy receptors
    Journal Name: The EMBO Journal
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.15252/embj.2022112767
    Citation Count: 77
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.